SUMMIT THERAPEUTICS INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.06 USD | -13.62% |
|
+14.37% | +55.56% |
| May. 01 | Transcript : Summit Therapeutics Inc., Q1 2024 Earnings Call, May 01, 2024 | |
| May. 01 | Summit Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Chart calendar Summit Therapeutics Inc.
cbe97c2693.yfUFlsM-u_lvE-TJwOHZ9Ge3VlUCrghpxweT5dP5Q-k.kbxD2ZlJ3pReSau9or7qjjf7FWJpmDwCtTDHr6mbKdu7tDLBp2TZvQhZqQ~c91aebd13ce839ba3ceca55b4c14be5a
Upcoming events on Summit Therapeutics Inc.
Past events on Summit Therapeutics Inc.
| 2024-05-01 09:00 am | Q1 2024 Earnings Call |
| 2024-05-01 07:00 am | Q1 2024 Earnings Release |
| 2024-04-16 02:30 pm | Stifel Virtual Targeted Oncology Days Conference - Fireside Chat |
| 2024-03-22 07:00 am | European Lung Cancer Congress - Presentation No 174P |
| 2024-03-22 07:00 am | European Lung Cancer Congress - Presentation No 68P |
| 2024-03-12 02:35 pm | Barclays Global Healthcare Conference |
| 2024-02-20 09:00 am | Q4 2023 Earnings Call |
| 2024-02-20 07:00 am | Q4 2023 Earnings Release |
| 2024-02-14 02:40 pm | Oppenheimer Healthcare Life Sciences Conference |
| 2024-01-09 04:30 pm | JPMorgan Healthcare Conference |
| 2023-11-07 09:00 am | Q3 2023 Earnings Call |
| 2023-11-07 07:00 am | Q3 2023 Earnings Release |
| 2023-11-04 02:55 pm | Society for Immunotherapy of Cancer Meeting - Abstract Number.: 1194 |
| 2023-10-11 | Extraordinary Shareholders Meeting |
| 2023-08-09 09:00 am | Q2 2023 Earnings Call |
| 2023-08-09 07:00 am | Q2 2023 Earnings Release |
| 2023-06-04 09:00 am | American Society of Clinical Oncology Meeting - Abstract No 9087 |
| 2023-05-23 01:00 pm | Annual General Meeting |
| 2023-05-11 09:00 am | Q1 2023 Earnings Call |
| 2023-05-11 07:30 am | Q1 2023 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2023 | 2024 |
|---|---|---|---|---|---|
|
Net sales Million GBP | Released Forecast Spread | 15,7 15,7 0.1% | 14,5 15,2 -4.37% | 0,00 | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 |
|
EBIT Million GBP | Released Forecast Spread | -25,3 -23,4 -8.21% | -38,3 -43,3 11.45% | 0,00 | -150 |
|
Earnings before Tax (EBT) Million GBP | Released Forecast Spread | -25,6 -21,6 -18.42% | 0,00 0,00 - | 0,00 | 0,00 |
|
Net income Million GBP | Released Forecast Spread | -22,0 -18,5 -18.95% | 0,00 0,00 - | -486 | 0,00 |
|
EPS GBP | Released Forecast Spread | -0,13 -0,12 -13.04% | 0,00 0,00 - | -0,78 | 0,00 |
| Announcement Date | 30/04/20 | 17/03/21 | 20/02/24 | - |
Quarterly results
| Fiscal Period | December | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|
|
Net sales Million GBP | Released Forecast Spread | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million GBP | Released Forecast Spread | -33,9 -31,6 -7% | -36,8 | -39,2 | -40,0 | -41,6 |
| Announcement Date | 01/05/24 | - | - | - | - |
More events
Past sector events for Summit Therapeutics Inc.
| 2024-05-02 04:05 pm | KURA ONCOLOGY, INC.: Q1 2024 Earnings Release |
| 2024-05-02 04:05 pm | ZYMEWORKS INC.: Q1 2024 Earnings Release |
| 2024-05-02 04:02 pm | ARDELYX, INC.: Q1 2024 Earnings Release |
| 2024-05-02 04:01 pm | LONGBOARD PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 2024-05-02 04:01 pm | ASCENDIS PHARMA A/S: Q1 2024 Earnings Release |
| 2024-05-02 04:00 pm | ULTRAGENYX PHARMACEUTICAL INC.: Q1 2024 Earnings Release |
| 2024-05-02 11:00 am | GENMAB A/S: Q1 2024 Earnings Release |
| 2024-05-02 07:00 am | GERON CORPORATION: Q1 2024 Earnings Release |
| 2024-05-02 07:00 am | AGIOS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 2024-05-02 07:00 am | BICYCLE THERAPEUTICS PLC: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- SMMT Stock
- Calendar Summit Therapeutics Inc.
